| Heart disease and stroke statistics—2020 update: a report from the American Heart Association SS Virani, A Alonso, EJ Benjamin, MS Bittencourt, CW Callaway, ... Circulation 141 (9), e139-e596, 2020 | 18376* | 2020 |
| American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee EJ Benjamin, P Muntner, A Alonso, MS Bittencourt, CW Callaway, ... Heart disease and stroke statistics-2019 update: a report from the American …, 2019 | 3302 | 2019 |
| American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee SS Virani, A Alonso, EJ Benjamin, MS Bittencourt, CW Callaway, ... Heart disease and stroke statistics-2020 update: a report from the American …, 2020 | 2562 | 2020 |
| American heart association council on E, prevention statistics c, stroke statistics s. heart disease and stroke statistics-2019 update: a report from the American heart association EJ Benjamin, P Muntner, A Alonso, MS Bittencourt, CW Callaway, ... Circulation 139 (10), e56-e528, 2019 | 530 | 2019 |
| Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population‐based study LB VanWagner, JE Wilcox, LA Colangelo, DM Lloyd‐Jones, JJ Carr, ... Hepatology 62 (3), 773-783, 2015 | 331 | 2015 |
| Redefining cirrhotic cardiomyopathy for the modern era M Izzy, LB VanWagner, G Lin, M Altieri, JY Findlay, JK Oh, KD Watt, ... Hepatology 71 (1), 334-345, 2020 | 309 | 2020 |
| Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events LB VanWagner, M Bhave, HS Te, J Feinglass, L Alvarez, ME Rinella Hepatology 56 (5), 1741-1750, 2012 | 256 | 2012 |
| Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial LB Van Wagner, SWP Koppe, EM Brunt, J Gottstein, K Gardikiotes, ... Annals of hepatology 10 (3), 277-286, 2016 | 229 | 2016 |
| High early cardiovascular mortality after liver transplantation LB VanWagner, B Lapin, J Levitsky, JT Wilkins, MM Abecassis, AI Skaro, ... Liver transplantation 20 (11), 1306-1316, 2014 | 213 | 2014 |
| Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals SB Prenner, LB VanWagner, SL Flamm, R Salem, RJ Lewandowski, ... Journal of hepatology 66 (6), 1173-1181, 2017 | 187 | 2017 |
| Factors associated with major adverse cardiovascular events after liver transplantation among a national sample LB VanWagner, M Serper, R Kang, J Levitsky, S Hohmann, M Abecassis, ... American Journal of Transplantation 16 (9), 2684-2694, 2016 | 184 | 2016 |
| North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension JR Boike, BG Thornburg, SK Asrani, MB Fallon, BE Fortune, MJ Izzy, ... Clinical Gastroenterology and Hepatology 20 (8), 1636-1662. e36, 2022 | 182 | 2022 |
| Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study LB VanWagner, H Ning, CE Lewis, CM Shay, J Wilkins, JJ Carr, JG Terry, ... Atherosclerosis 235 (2), 599-605, 2014 | 160 | 2014 |
| Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: an evaluation of the evidence and consensus recommendations LB VanWagner, ME Harinstein, JR Runo, C Darling, M Serper, S Hall, ... American Journal of Transplantation 18 (1), 30-42, 2018 | 151 | 2018 |
| Extrahepatic manifestations of nonalcoholic fatty liver disease LB VanWagner, ME Rinella Current hepatology reports 15 (2), 75-85, 2016 | 120 | 2016 |
| Longitudinal association of non‐alcoholic fatty liver disease with changes in myocardial structure and function: the CARDIA study LB VanWagner, JE Wilcox, H Ning, CE Lewis, JJ Carr, ME Rinella, ... Journal of the American Heart Association 9 (4), e014279, 2020 | 117 | 2020 |
| Gestational diabetes mellitus is strongly associated with non-alcoholic fatty liver disease VH Ajmera, EP Gunderson, LB VanWagner, CE Lewis, JJ Carr, ... Official journal of the American College of Gastroenterology| ACG 111 (5 …, 2016 | 116 | 2016 |
| A point‐based prediction model for cardiovascular risk in orthotopic liver transplantation: the CAR‐OLT score LB VanWagner, H Ning, M Whitsett, J Levitsky, S Uttal, JT Wilkins, ... Hepatology 66 (6), 1968-1979, 2017 | 114 | 2017 |
| The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis LB Van Wagner, ME Rinella Therapeutic advances in gastroenterology 4 (4), 249-263, 2011 | 104 | 2011 |
| Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review M Whitsett, LB VanWagner World journal of hepatology 7 (16), 2041, 2015 | 103 | 2015 |